296 related articles for article (PubMed ID: 27197162)
1. Endothelial Side Population Cells Contribute to Tumor Angiogenesis and Antiangiogenic Drug Resistance.
Naito H; Wakabayashi T; Kidoya H; Muramatsu F; Takara K; Eino D; Yamane K; Iba T; Takakura N
Cancer Res; 2016 Jun; 76(11):3200-10. PubMed ID: 27197162
[TBL] [Abstract][Full Text] [Related]
2. Rapid vascular regrowth in tumors after reversal of VEGF inhibition.
Mancuso MR; Davis R; Norberg SM; O'Brien S; Sennino B; Nakahara T; Yao VJ; Inai T; Brooks P; Freimark B; Shalinsky DR; Hu-Lowe DD; McDonald DM
J Clin Invest; 2006 Oct; 116(10):2610-21. PubMed ID: 17016557
[TBL] [Abstract][Full Text] [Related]
3. The receptor tyrosine kinase inhibitor SU11248 impedes endothelial cell migration, tubule formation, and blood vessel formation in vivo, but has little effect on existing tumor vessels.
Osusky KL; Hallahan DE; Fu A; Ye F; Shyr Y; Geng L
Angiogenesis; 2004; 7(3):225-33. PubMed ID: 15609077
[TBL] [Abstract][Full Text] [Related]
4. Decursin inhibits vasculogenesis in early tumor progression by suppression of endothelial progenitor cell differentiation and function.
Jung SY; Choi JH; Kwon SM; Masuda H; Asahara T; Lee YM
J Cell Biochem; 2012 May; 113(5):1478-87. PubMed ID: 22298358
[TBL] [Abstract][Full Text] [Related]
5. Endothelial progenitor cells do not contribute to tumor endothelium in primary and metastatic tumors.
Wickersheim A; Kerber M; de Miguel LS; Plate KH; Machein MR
Int J Cancer; 2009 Oct; 125(8):1771-7. PubMed ID: 19582874
[TBL] [Abstract][Full Text] [Related]
6. Angiogenic impairment of the vascular endothelium: a novel mechanism and potential therapeutic target in muscular dystrophy.
Palladino M; Gatto I; Neri V; Straino S; Smith RC; Silver M; Gaetani E; Marcantoni M; Giarretta I; Stigliano E; Capogrossi M; Hlatky L; Landolfi R; Pola R
Arterioscler Thromb Vasc Biol; 2013 Dec; 33(12):2867-76. PubMed ID: 24072696
[TBL] [Abstract][Full Text] [Related]
7. B55α/PP2A Limits Endothelial Cell Apoptosis During Vascular Remodeling: A Complementary Approach To Disrupt Pathological Vessels?
Ehling M; Celus W; Martín-Pérez R; Alba-Rovira R; Willox S; Ponti D; Cid MC; Jones EAV; Di Conza G; Mazzone M
Circ Res; 2020 Aug; 127(6):707-723. PubMed ID: 32527198
[TBL] [Abstract][Full Text] [Related]
8. Vascular endothelial growth inhibitor (VEGI; TNFSF15) inhibits bone marrow-derived endothelial progenitor cell incorporation into Lewis lung carcinoma tumors.
Liang PH; Tian F; Lu Y; Duan B; Stolz DB; Li LY
Angiogenesis; 2011 Mar; 14(1):61-8. PubMed ID: 21188501
[TBL] [Abstract][Full Text] [Related]
9. SU11248 maintenance therapy prevents tumor regrowth after fractionated irradiation of murine tumor models.
Schueneman AJ; Himmelfarb E; Geng L; Tan J; Donnelly E; Mendel D; McMahon G; Hallahan DE
Cancer Res; 2003 Jul; 63(14):4009-16. PubMed ID: 12873999
[TBL] [Abstract][Full Text] [Related]
10. Opposite angiogenic outcome of curcumin against ischemia and Lewis lung cancer models: in silico, in vitro and in vivo studies.
Fan S; Xu Y; Li X; Tie L; Pan Y; Li X
Biochim Biophys Acta; 2014 Sep; 1842(9):1742-54. PubMed ID: 24970744
[TBL] [Abstract][Full Text] [Related]
11. Bone marrow-derived lin(-)c-kit(+)Sca-1+ stem cells do not contribute to vasculogenesis in Lewis lung carcinoma.
Shinde Patil VR; Friedrich EB; Wolley AE; Gerszten RE; Allport JR; Weissleder R
Neoplasia; 2005 Mar; 7(3):234-40. PubMed ID: 15799823
[TBL] [Abstract][Full Text] [Related]
12. Delta-like ligand 4-targeted nanomedicine for antiangiogenic cancer therapy.
Liu YR; Guan YY; Luan X; Lu Q; Wang C; Liu HJ; Gao YG; Yang SC; Dong X; Chen HZ; Fang C
Biomaterials; 2015 Feb; 42():161-71. PubMed ID: 25542804
[TBL] [Abstract][Full Text] [Related]
13. Mechanism of inhibition of tumor angiogenesis by beta-hydroxyisovalerylshikonin.
Komi Y; Suzuki Y; Shimamura M; Kajimoto S; Nakajo S; Masuda M; Shibuya M; Itabe H; Shimokado K; Oettgen P; Nakaya K; Kojima S
Cancer Sci; 2009 Feb; 100(2):269-77. PubMed ID: 19200258
[TBL] [Abstract][Full Text] [Related]
14. Estrogen enhances tumor growth and angiogenesis indirectly via mediation of bone marrow‑derived cells as well as directly through stimulation of tumor and endothelial cells.
Zhuo Y; Li X; Zheng Q; Fan X; Ma W; Chen J; Zhao X; Zhao P; Liu X; Tang F; Cheng K; Feng W
Oncol Rep; 2018 Oct; 40(4):2147-2156. PubMed ID: 30106454
[TBL] [Abstract][Full Text] [Related]
15. Metronomic low-dose chemotherapy boosts CD95-dependent antiangiogenic effect of the thrombospondin peptide ABT-510: a complementation antiangiogenic strategy.
Yap R; Veliceasa D; Emmenegger U; Kerbel RS; McKay LM; Henkin J; Volpert OV
Clin Cancer Res; 2005 Sep; 11(18):6678-85. PubMed ID: 16166447
[TBL] [Abstract][Full Text] [Related]
16. Cytochalasin E, an epoxide containing Aspergillus-derived fungal metabolite, inhibits angiogenesis and tumor growth.
Udagawa T; Yuan J; Panigrahy D; Chang YH; Shah J; D'Amato RJ
J Pharmacol Exp Ther; 2000 Aug; 294(2):421-7. PubMed ID: 10900214
[TBL] [Abstract][Full Text] [Related]
17. HGF/NK4, a four-kringle antagonist of hepatocyte growth factor, is an angiogenesis inhibitor that suppresses tumor growth and metastasis in mice.
Kuba K; Matsumoto K; Date K; Shimura H; Tanaka M; Nakamura T
Cancer Res; 2000 Dec; 60(23):6737-43. PubMed ID: 11118060
[TBL] [Abstract][Full Text] [Related]
18. Deguelin inhibits vasculogenic function of endothelial progenitor cells in tumor progression and metastasis via suppression of focal adhesion.
Nguyen MP; Lee D; Lee SH; Lee HE; Lee HY; Lee YM
Oncotarget; 2015 Jun; 6(18):16588-600. PubMed ID: 26078334
[TBL] [Abstract][Full Text] [Related]
19. Bone marrow-derived circulating endothelial precursors do not contribute to vascular endothelium and are not needed for tumor growth.
Purhonen S; Palm J; Rossi D; Kaskenpää N; Rajantie I; Ylä-Herttuala S; Alitalo K; Weissman IL; Salven P
Proc Natl Acad Sci U S A; 2008 May; 105(18):6620-5. PubMed ID: 18443294
[TBL] [Abstract][Full Text] [Related]
20. Irradiation-induced angiogenesis through the up-regulation of the nitric oxide pathway: implications for tumor radiotherapy.
Sonveaux P; Brouet A; Havaux X; Grégoire V; Dessy C; Balligand JL; Feron O
Cancer Res; 2003 Mar; 63(5):1012-9. PubMed ID: 12615716
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
